VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $130,476,000 | -73.7% | 4,961,079 | +1.6% | 3.55% | -68.5% |
| Q4 2015 | $496,239,000 | -28.6% | 4,881,835 | +25.2% | 11.26% | -25.2% |
| Q3 2015 | $695,441,000 | +14.4% | 3,898,648 | +42.5% | 15.04% | +13.6% |
| Q2 2015 | $607,946,000 | +97.4% | 2,736,647 | +27.2% | 13.24% | +50.4% |
| Q4 2014 | $307,955,000 | -34.4% | 2,151,874 | -39.8% | 8.80% | -40.9% |
| Q3 2014 | $469,302,000 | +30.5% | 3,576,998 | +25.5% | 14.87% | +10.6% |
| Q2 2014 | $359,590,000 | +12.2% | 2,851,175 | +17.3% | 13.45% | -1.6% |
| Q1 2014 | $320,473,000 | +28.1% | 2,430,955 | +14.1% | 13.67% | +4.8% |
| Q4 2013 | $250,215,000 | +12.5% | 2,131,300 | 0.0% | 13.05% | +5.2% |
| Q3 2013 | $222,359,000 | +12.0% | 2,131,300 | -7.6% | 12.40% | +14.5% |
| Q2 2013 | $198,587,000 | – | 2,307,000 | – | 10.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |